Live birth rate after female fertility preservation for cancer or haematopoietic stem cell transplantation: a systematic review and meta-analysis of the three main techniques; embryo, oocyte and ovarian tissue cryopreservation

Author:

Fraison E123ORCID,Huberlant S45,Labrune E123,Cavalieri M6,Montagut M7,Brugnon F89ORCID,Courbiere B1011ORCID

Affiliation:

1. Service de Médecine de la Reproduction, Hospices Civils de Lyon, Hôpital Mère Enfant , Bron, France

2. Université Claude Bernard, Faculté de Médecine Laennec , Lyon, France

3. INSERM Unité 1208 , Bron, France

4. Service de Gynécologie Obstétrique et Médecine de la Reproduction, CHU Carémeau , Nîmes, France

5. Université de Montpellier-Nîmes , Nîmes Cedex 2, France

6. Service de Gynécologie-Obstétrique et Médecine de la Reproduction, CHU François Mitterrand , Dijon, France

7. Service de Médecine de la Reproduction, Clinique Croix du Sud , Quint-Fonsegrives, France

8. Assistance Médicale à la Procréation, CECOS, CHU Clermont Ferrand, CHU Estaing , Clermont-Ferrand, France

9. Université Clermont Auvergne, IMoST, INSERM 1240, Faculté de Médecine , Clermont-Ferrand, France

10. Service d’Assistance Médicale à la Procréation, Plateforme Cancer & Fertilité OncoPACA-Corse, AP-HM, Hôpital La Conception , Marseille, France

11. Aix-Marseille Université, IMBE, CNRS, IRD, Avignon Université , Marseille, France

Abstract

AbstractSTUDY QUESTIONWhat are the chances of achieving a live birth after embryo, oocyte and ovarian tissue cryopreservation (OTC) in female cancer survivors?SUMMARY ANSWERThe live birth rates (LBRs) following embryo and oocyte cryopreservation are 41% and 32%, respectively, while for IVF and spontaneous LBR after tissue cryopreservation and transplantation, these rates are 21% and 33%, respectively.WHAT IS KNOWN ALREADYCurrently, fertility preservation (FP) has become a major public health issue as diagnostic and therapeutic progress has made it possible to achieve an 80% survival rate in children, adolescents and young adults with cancer. In the latest ESHRE guidelines, only oocyte and embryo cryopreservation are considered as established options for FP. OTC is still considered to be an innovative method, while it is an acceptable FP technique in the American Society for Reproductive Medicine guidelines. However, given the lack of studies on long-term outcomes after FP, it is still unclear which technique offers the best chance to achieve a live birth.STUDY DESIGN, SIZE, DURATIONWe performed a systematic review and meta-analysis of published controlled studies. Searches were conducted from January 2004 to May 2021 in Medline, Embase and the Cochrane Library using the following search terms: cancer, stem cell transplantation, FP, embryo cryopreservation, oocyte vitrification, OTC and reproductive outcome.PARTICIPANTS/MATERIALS, SETTING, METHODSA total of 126 full-text articles were preselected from 1436 references based on the title and abstract and assessed via the Newcastle–Ottawa Quality Assessment Scale. The studies were selected, and their data were extracted by two independent reviewers according to the Cochrane methods. A fixed-effect meta-analysis was performed for outcomes with high heterogeneity.MAIN RESULTS AND THE ROLE OF CHANCEData from 34 studies were used for this meta-analysis. Regarding cryopreserved embryos, the LBR after IVF was 41% (95% CI: 34–48, I2: 0%, fixed effect). Concerning vitrified oocytes, the LBR was 32% (95% CI: 26–39, I2: 0%, fixed effect). Finally, the LBR after IVF and the spontaneous LBR after ovarian tissue transplantation were 21% (95% CI: 15–26, I2: 0%, fixed-effect) and 33% (95% CI: 25–42, I2: 46.1%, random-effect), respectively. For all outcomes, in the sensitivity analyses, the maximum variation in the estimated percentage was 1%.LIMITATIONS, REASONS FOR CAUTIONThe heterogeneity of the literature prevents us from comparing these three techniques. This meta-analysis provides limited data which may help clinicians when counselling patients.WIDER IMPLICATIONS OF THE FINDINGSThis study highlights the need for long-term follow-up registries to assess return rates, as well as spontaneous pregnancy rates and birth rates after FP.STUDY FUNDING/COMPETING INTEREST(S)This work was sponsored by an unrestricted grant from GEDEON RICHTER France. The authors have no competing interests to declare.REGISTRATION NUMBERCRD42021264042.

Funder

GEDEON RICHTER France

Publisher

Oxford University Press (OUP)

Subject

Obstetrics and Gynecology,Rehabilitation,Reproductive Medicine

Reference55 articles.

1. Fertility preservation in female oncology patients: the influence of the type of cancer on ovarian stimulation response;Alvarez;Hum Reprod,2018

2. Uptake and outcome of assisted reproductive techniques in long-term survivors of SCT;Babb;Bone Marrow Transplant,2012

3. Fifteen-year follow-up of embryos cryopreserved in cancer patients for fertility preservation;Barcroft;J Assist Reprod Genet,2013

4. Fertility preservation with ovarian stimulation and time to treatment in women with stage II–III breast cancer receiving neoadjuvant therapy;Chien;Breast Cancer Res Treat,2017

5. Elective and onco-fertility preservation: factors related to IVF outcomes;Cobo;Hum Reprod,2018

Cited by 38 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3